Literature DB >> 10454019

Early metabolic changes in peripheral blood cells of renal transplant recipients treated with cyclosporine A.

R Rezzani1, L Rodella, R Bianchi.   

Abstract

We histochemically examined (phosphatase acid-AcP, phosphatase alkaline-ALP, succinate dehydrogenase-SDH, lactate dehydrogenase-LDH) the peripheral blood of renal transplant recipients and controls before (day 0) and after Cyclosporine A (CsA) treatment (days 1, 2, 7 and 30). We wanted to detect the metabolic changes induced in the CsA resistant cells (leucocytes) by CsA and to evaluate the early effects determined by the drug. There was no difference in enzyme activities between the control group and renal patients before CsA treatment (day 0). AcP and ALP activity increased 1 day after CsA administration and became similar to the control by the day 30. LDH activity increased one day after CsA treatment and remained high during the treatment period (30 days), while SDH activity did not change. These enzymatic variations may suggest that the LDH enzyme is involved in the drug degradation as are other phosphatase and oxidoreductase enzymes (i.e. cytochrome P450). Moreover, the high activity of LDH, the enzyme responsible for interconversion of pyruvate in lactic acid, would indicate that anaerobic glycolysis is preferentially used in the pyruvate pathway. However, SDH did not seem to be directly involved in CsA metabolism. Our findings showed that the CsA treatment induced clear variations of the activity of the cellular phosphatase and oxidoreductase enzymes from the first days of drug administration. The variation of the enzymes studied and the appearance time and duration of the metabolic changes, may be markers of the cellular stress due to CsA internalization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10454019     DOI: 10.1016/s0192-0561(99)00026-0

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  3 in total

1.  Predictive model for delayed graft function based on easily available pre-renal transplant variables.

Authors:  Gianluigi Zaza; Pietro Manuel Ferraro; Gianpaolo Tessari; Silvio Sandrini; Maria Piera Scolari; Irene Capelli; Enrico Minetti; Loreto Gesualdo; Giampiero Girolomoni; Giovanni Gambaro; Antonio Lupo; Luigino Boschiero
Journal:  Intern Emerg Med       Date:  2014-08-28       Impact factor: 3.397

Review 2.  Personalization of the immunosuppressive treatment in renal transplant recipients: the great challenge in "omics" medicine.

Authors:  Gianluigi Zaza; Simona Granata; Paola Tomei; Alessandra Dalla Gassa; Antonio Lupo
Journal:  Int J Mol Sci       Date:  2015-02-17       Impact factor: 5.923

3.  Karyopherins: potential biological elements involved in the delayed graft function in renal transplant recipients.

Authors:  Gianluigi Zaza; Federica Rascio; Paola Pontrelli; Simona Granata; Patrizia Stifanelli; Matteo Accetturo; Nicola Ancona; Loreto Gesualdo; Antonio Lupo; Giuseppe Grandaliano
Journal:  BMC Med Genomics       Date:  2014-03-14       Impact factor: 3.063

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.